Aleksandra Markovets

Company: AstraZeneca

Job title: Director

Seminars:

Background Variability of ctDNA Levels in Plasma of Patients with Advanced Lung Cancer in the Absence of Treatment 11:00 am

Quantifying changes in circulating tumor DNA (ctDNA) can rapidly identify patients responding to therapy Accurate quantification of ctDNA levels is required and it’s important to understand biological and technical variabilities in ctDNA measurements The results of our analysis of technical and biological variability of ctDNA levels in pre-treatment samples from patients with advanced EGFRm NSCLC,…Read more

day: Day Two